These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20859496)

  • 1. Rifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature review.
    Khan FY; Rasoul F
    Indian J Crit Care Med; 2010 Apr; 14(2):97-100. PubMed ID: 20859496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of treatment of latent tuberculosis infection in compensated cirrhotic patients during transplant candidacy period.
    Jahng AW; Tran T; Bui L; Joyner JL
    Transplantation; 2007 Jun; 83(12):1557-62. PubMed ID: 17589337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline abnormal liver function tests are more important than age in the development of isoniazid-induced hepatoxicity for patients receiving preventive therapy for latent tuberculosis infection.
    Gray EL; Goldberg HF
    Intern Med J; 2016 Mar; 46(3):281-7. PubMed ID: 26648478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of adverse effects with antituberculosis chemotherapy].
    Tsuyuguchi K; Wada M
    Kekkaku; 2011 Feb; 86(2):87-99. PubMed ID: 21404653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selected pharmaceutical excipient prevent isoniazid and rifampicin induced hepatotoxicity.
    Shih TY; Ho SC; Hsiong CH; Huang TY; Hu OY
    Curr Drug Metab; 2013 Jul; 14(6):720-8. PubMed ID: 23701163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment.
    Bray MG; Poulain C; Dougados M; Gossec L
    Joint Bone Spine; 2010 Mar; 77(2):135-41. PubMed ID: 20097592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot aqueous leaf extract of Lasianthera africana (Icacinaceae) attenuates rifampicin-isoniazid-induced hepatotoxicity.
    Nwidu LL; Teme RE
    J Integr Med; 2018 Jul; 16(4):263-272. PubMed ID: 29776838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoniazid hepatotoxicity with clinical and histopathology correlate.
    Gourishankar A; Navarro F; Debroy AN; Smith KC
    Ann Clin Lab Sci; 2014; 44(1):87-90. PubMed ID: 24695480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of garlic on isoniazid and rifampicin-induced hepatic injury in rats.
    Pal R; Vaiphei K; Sikander A; Singh K; Rana SV
    World J Gastroenterol; 2006 Jan; 12(4):636-9. PubMed ID: 16489682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of different oral doses of isoniazid-rifampicin in rats.
    Rana SV; Pal R; Vaiphie K; Singh K
    Mol Cell Biochem; 2006 Sep; 289(1-2):39-47. PubMed ID: 16583132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid-rifampicin induced lipid changes in rats.
    Pal R; Rana SV; Vaiphei K; Singh K
    Clin Chim Acta; 2008 Mar; 389(1-2):55-60. PubMed ID: 18157944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
    Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
    Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse effects and adherence to treatment of rifampicin 4 months vs isoniazid 6 months for latent tuberculosis: a retrospective analysis.
    Fresard I; Bridevaux PO; Rochat T; Janssens JP
    Swiss Med Wkly; 2011; 141():w13240. PubMed ID: 21842452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement.
    Ikegame S; Wakamatsu K; Fujita M; Nakanishi Y; Harada M; Kajiki A
    J Infect Chemother; 2011 Oct; 17(5):689-93. PubMed ID: 21327690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Accidental Isoniazid Overdose Presenting With Nonspecific Symptoms.
    Asiimwe E; Koh M; Patel R
    Cureus; 2022 Mar; 14(3):e23218. PubMed ID: 35449637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals.
    Eminzade S; Uraz F; Izzettin FV
    Nutr Metab (Lond); 2008 Jul; 5():18. PubMed ID: 18601745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury.
    Wang C; Fan RQ; Zhang YX; Nie H; Li K
    World J Gastroenterol; 2016 Nov; 22(44):9775-9783. PubMed ID: 27956801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure: A Case Report and Review of the Literature.
    Li X; Liu Y; Zhang E; He Q; Tang YB
    Medicine (Baltimore); 2015 Dec; 94(49):e1665. PubMed ID: 26656321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.